The Role of Endothelin 1 as a Marker of Renal Impairment in Sickle Cell Disease

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Sickle cell disease (SCD) refers to a group of hemoglobinopathies that include mutations in the gene encoding the beta subunit of hemoglobin. Within the umbrella of SCD, many subgroups exist, namely sickle cell anemia (SCA), hemoglobin SC disease (HbSC), and hemoglobin sickle-beta-thalassemia (beta-thalassemia positive or beta-thalassemia negative). Several other minor variants within the group of SCDs also, albeit not as common as the varieties mentioned above. It is essential to mention the sickle cell trait (HbAS), which carries a heterozygous mutation and seldom presents clinical signs or symptoms. Sickle cell anemia is the most common form of SCD

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1
Maximum Age: 18
Healthy Volunteers: t
View:

• The patients fulfilling all the following criteria will be included:

• Patients with sickle cell disease in the age range of 1-18years.

Locations
Other Locations
Egypt
Sohag university Hospital
RECRUITING
Sohag
Contact Information
Primary
Esraa A Quenawey, resident
esraaanwar@med.sohag.edu.eg
01026841188
Backup
Alzahraa A Ahmed, professor
Time Frame
Start Date: 2023-10-24
Estimated Completion Date: 2024-10-23
Participants
Target number of participants: 30
Sponsors
Leads: Sohag University

This content was sourced from clinicaltrials.gov